Steris | STE - Fremdkapital





Fremdkapital Veränderung Datum
3M USD 10.9B 2M 2026-06
Accuray USD 124.78M 2.54M 2025-12
Baxter International USD 8.62B 6M 2026-06
Becton, Dickinson and Co. USD 13.51B 1.2B 2026-06
Boston Scientific USD 10.86B 148M 2026-03
CONMED USD 657.05M 203.11M 2026-06
Cooper Companies USD 1.86B 17.7M 2026-03
Dexcom USD 1.3B 200K 2026-06
Ecolab USD 11.91B 4.98B 2026-06
Edwards Lifesciences USD 598.7M 1.3M 2026-06
Fortive USD 3.51B 920M 2026-06
Getinge SEK 9.09B 167M 2026-06
Globus Medical USD 398K 38K 2026-03
Haemonetics USD 1.17B 50.36M 2026-06
Idexx Laboratories USD 299.86M 11K 2026-06
Inogen USD 0 0 2022-06
Insulet USD 929.5M 0 2026-06
Integra LifeSciences USD 1.83B 2.05M 2026-06
Intuitive Surgical USD 0 0 2025-03
J&J USD 37.34B 183M 2026-06
Olympus JPY 179.76B 20.07B 2026-06
Orthofix International USD 221.59M 256K 2026-06
Owens Minor USD 1.8B 35.38M 2025-12
ResMed USD 399.42M 4.75M 2026-06
Steris USD 1.65B 162.6M 2026-06
Stryker USD 14.19B 32M 2026-06
Tandem Diabetes Care USD 602.58M 809K 2026-06
Teleflex USD 2.72B 206.24M 2026-06
Thermo Fisher Scientific USD 39.18B 890M 2026-06
Zimmer Biomet Holdings USD 6.28B 17.6M 2026-06